Hematocrit and hemoglobin are independently related to insulin resistance and compensatory hyperinsulinemia in healthy, non-obese men and women

Metabolism: Clinical and Experimental

Volumn 47, Issue 7, 1998, Pages 831-835

  Facchini, Francesco S ^b   Carantoni, Marcello ^b   Jeppesen, Jorgen ^b   Reaven, Gerald M ^a  

^a Shaman Pharmaceuticals Inc   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031838572     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90121-4     Document Type: Article

References (27)

1. Moan A, Nordby G, Os I, et al: Relationship between hemorrheologic factors and insulin sensitivity in healthy young men. Metabolism 43:423-427, 1994
2. Wannamethee GS, Perry IJ, Shaper AG: Hematocrit and risk of NIDDM. Diabetes 45:576-579, 1996
3. Sicree RA, Zimmet PZ, King HOM, et al: Plasma insulin response among Nauruans: Prediction of deterioration in glucose tolerance over 6 yr. Diabetes 36:179-186, 1987
4. Haffner SM, Stern MP, Mitchell BD, et al: Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes 39:283-288, 1990
5. Warram JH, Martin BC, Krowleski AS, et al: Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic patients. Ann Intern Med 113:909-915, 1990
6. Lillioja S, Mott DM, Spraul M, et al: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. N Engl J Med 329:1988-1992, 1993
7. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
8. Kadish AH, Litle RH, Sternberg JC: A new and rapid method for determination of glucose by measurement of rate of oxygen consumption. Clin Chem 14:116-131, 1968
9. Hales CN, Randle PJ: Immunoassay of insulin with insulin-antibody precipitate. Biochem J 88:137-146, 1963
10. Shen D-C, Shieh S-M, Fuh M-T, et al: Resistance to insulin-stimulated-glucose uptake in patients with hypertension. J Clin Endocrinol Metab 66:580-583, 1988
11. Bucolo G, David H: Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19:476-482, 1973
12. Allain CA, Poon LS, Chan CSG, et al: Enzymatic determination of total serum cholesterol. Clin Chem 20:470-475, 1974
13. Havel RJ, Eder HA, Bragdon JH: The distribution of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34:1345-1353, 1955
14. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1495-1507, 1988
15. Hollenbeck CB, Chen N, Chen Y-DI, et al: Relationship between the plasma insulin response to oral glucose and insulin-stimulated glucose utilization in normal subjects. Diabetes 33:460-463, 1984
16. Austin MA: Plasma triglycerides any coronary heart disease. Arteriosclerosis Thrombosis 11:2-14, 1991
17. Letcher RL, Chien S, Pickering TG, et al: Elevated blood viscosity in patients with borderline essential hypertension. Hypertension 5:757-762, 1983
18. Deveraux RB, Drayer JIM, Chien S, et al: Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension. Am J Cardiol 54:595-595, 1984
19. de Simone G, Deveraux RB, Chien S, et al: Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation 81:107-117, 1990
20. Baron AD, Steinberg H, Brechtel G, et al: Skeletal muscle blood flow independently modulates insulin-mediated glucose uptake. Am J Physiol 266:E248-253, 1994
21. Facchini F, Hollenbeck CB, Chen YN, et al: Demonstration of a relationship between white blood cell count, insulin resistance, and several risk factors for coronary heart disease in women. J Intern Med 232:267-272, 1992
22. Jeppesen JL, Maheux P, Facchini FS: White blood cell count and insulin resistance in healthy nonsmoking men. Am Heart J 127:459-461, 1994
23. Facchini FS, Stoohs R, Reaven GM: Enhanced sympathetic nervous system activity - the linchpin between insulin resistance, hyperinsulinemia, and heart rate. Am J Hypertens 9:1013-1017, 1996
24. Takaku F, Hirashima K, Okinaka S: Effect of bilateral section of the splanchnic nerve on erythropoiesis. Nature 191:500-501, 1961
25. Patel P, Mendall MA, Carrington D, et al: Association of Helicobacter pylon and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 311:711-714, 1995
26. Kuller LH, Tracy RP, Shaten J, et al: Relation of C-reactive protein and coronary heart-disease in the MRFIT nested case control study. Am J Epidemiol 144:537-547, 1996
27. Haverkate F, Thompson SG, Pyke SDM, et al: Production of c-reactive protein and risk of coronary events in stable and unstable angina. Lancet 349:462-466, 1997